Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.03.2026 UIGB IE00079WNSI6 8,816.00 GBP 222,429.29 25.230 ...
-
ATLGS Introduces 'Fragment Mode' for MOVINdow Multi Video Player — Real-Time Video Fragmentation Technology, Pioneering a New Era in Video
TOKYO--(BUSINESS WIRE)--A new dimension in video: ATLGS unveils Fragment Mode for MOVINdow Multi Video Player — Real-Time Video Fragmentation with patented technologies....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.03.2026 UNCU.LN IE00BD6GCF16 797,510.00 USD 34,995,597.17 43.881 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.03.2026 UINC IE00BZBW4Z27 9,858,024.00 USD 363,288,519.61 36.852 ...
-
INVESTOR DEADLINE: Gartner, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO--(BUSINESS WIRE)--Case alleges Gartner was not equipped to handle ongoing challenges in its industry to meet consulting revenue targets or maintain its CV growth rate....
-
Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms
BOSTON--(BUSINESS WIRE)--Leveragen, a Boston-based biotechnology company developing next-generation in vivo platforms for antibody discovery, today announced a collaboration agreement with Daiichi Sankyo (TSE: 4568) to support research efforts in advanced biologics. Under the collaboration, Daiichi Sankyo will work with Leveragen to apply Leveragen’s in vivo antibody discovery capabilities in support of selected research programs. The collaboration reflects a shared interest in exploring innova...
-
SmartBear Survey: 70% of Software Experts Concerned that Application Quality is Suffering Given Faster AI Code Development
SOMERVILLE, Mass.--(BUSINESS WIRE)--SmartBear, helping teams build, test, and ship quality software at AI speed and scale, today released a survey that finds 70% of software experts say application quality has already degraded as AI accelerates development, and 60% already experienced quality issues in the past year as application development outpaced testing. The survey of 273 CTOs, CIOs, software developers, quality assurance directors, and others–almost three quarters at director level or ab...
-
PepsiCo Named Official Beverage Partner of VENU’s Premium Sunset Amphitheater Portfolio
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), owner, operator, and developer of premium entertainment and hospitality destinations, today announced that PepsiCo (NASDAQ: PEP), has partnered with VENU as the Official Beverage Supplier for its expanding Sunset Amphitheater portfolio and beyond. Through the partnership, PepsiCo’s globally recognized beverage brands will be featured across VENU’s Sunset Amphitheaters, beginning w...
-
SmartBear Introduces BearQ™Autonomous Testing for Software Applications, Sets New Standard for Application Integrity
SOMERVILLE, Mass.--(BUSINESS WIRE)--SmartBear, helping teams build, test, and ship quality software at AI speed and scale, today announced the release of BearQ, the agentic QA system with always-on teammates that autonomously explore, learn, and test applications, delivering continuous application integrity so software works as intended. BearQ is a foundational part of SmartBear’s product suite, the SmartBear Application Integrity Core™, that spans the SDLC and meets customers where they are in...
-
Nebius Group Announces Pricing of Upsized Private Offering of $4.0 Billion of Convertible Senior Notes
AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. (“Nebius Group” or the “Company”; NASDAQ: NBIS), a leading AI infrastructure company, today announced the pricing of its offering of $4.0 billion aggregate original principal amount of convertible senior notes, in two series: $2.25 billion aggregate original principal amount of 1.250% convertible notes due 2031 (the “2031 Notes”) and $1.75 billion aggregate original principal amount of 2.625% convertible notes due 2033 (the “2033 Notes”, and togethe...